← Open Payments lookup

GENE NOCHTA: Open Payments

NPI 1477521326 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,392 in 45 payments from 16 companies in 2025. Trend: 2023 $862 · 2024 $1,488 · 2025 $1,392

Food & beverage: $1,392
CompanyPaymentsAmount
Novo Nordisk Inc8$229
Vanda Pharmaceuticals Inc.7$187
Otsuka America Pharmaceutical, Inc.3$139
Paratek Pharmaceuticals, Inc.4$136
Regeneron Healthcare Solutions, Inc.1$125
E.R. Squibb & Sons, L.L.C.1$115
Sumitomo Pharma America, Inc.5$103
Teva Pharmaceuticals USA, Inc.1$96
ABBVIE INC.3$61
Amgen Inc.2$38

Products named: FANAPT, Ozempic, REXULTI, NUZYRA, DUPIXENT, COBENFY, GEMTESA, AUSTEDO XR.

Industry payments across KY — which companies pay providers there.